drug · antibody drug conjugate
patient view →anvatabart opadotin
Phase 2updated 2mo agoby Ambrx Biopharma Inc🔗 ChEMBL
Phase 2community read0 votes
Antibody drug conjugate drug with a maximum clinical stage of Phase 2 3 (across all indications), with 5 investigational indications.
targets
TubulinReceptor tyrosine-protein kinase erbB-2
all catalysts(0)
nothing on the calendar yet
News(0)
no news has mentioned this drug yet
comments(0)
5-min edit window · permanent after that